Enediynes: Exploration of microbial genomics to discover new anticancer drug leads

Bioorg Med Chem Lett. 2015 Jan 1;25(1):9-15. doi: 10.1016/j.bmcl.2014.11.019. Epub 2014 Nov 14.

Abstract

The enediyne natural products have been explored for their phenomenal cytotoxicity. The development of enediynes into anticancer drugs has been successfully achieved through the utilization of polymer- and antibody-drug conjugates (ADCs) as drug delivery systems. An increasing inventory of enediynes would benefit current application of ADCs in many oncology programs. Innovations in expanding the enediyne inventory should take advantage of the current knowledge of enediyne biosynthesis and post-genomics technologies. Bioinformatics analysis of microbial genomes reveals that enediynes are underexplored, in particular from Actinomycetales. This digest highlights the emerging opportunities to explore microbial genomics for the discovery of novel enediyne natural products.

Keywords: ADC payload; Biosynthetic gene cluster; Enediyne polyketide synthase; Genome mining; Natural products.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Antineoplastic Agents / chemistry*
  • Antineoplastic Agents / pharmacology
  • Drug Discovery / trends*
  • Enediynes / chemistry*
  • Enediynes / pharmacology
  • Genome, Microbial / drug effects
  • Genome, Microbial / genetics*
  • Genomics / trends*
  • Humans

Substances

  • Antineoplastic Agents
  • Enediynes